Cellular identity, developmental reorganization, genomic structure modulation, and susceptibility to neurodegenerative diseases involve epigenomic regulation engaging multiple signaling interplay. Here we demonstrate that elovanoids (ELVs), mediators derived from very-long-chain polyunsaturated fatty acids (VLC-PUFAs, n-3, C >28), and their precursors in human neurons/astrocytes in culture overcome the damage triggered by oligomeric amyloid-β (OAβ), erastin (ferroptosis-dependent cell death), or other insults like uncompensated oxidative stress (UOS), NMDA mediated cellular excitotoxicity, or oxygen-glucose deprivation (OGD), that target epigenomic signaling. We uncover that ELVs counteract damage targeting histones H3K9 and H3K27 methylation and acetylation; tau hyperphosphorylation (pThr181, pThr217, pThr231, and pSer202/pThr205 (AT8)); senescence gene programming (p16INK4a, p27KIP, p21CIP1, and p53); and DNA methylation (DNAm) modifying enzymes: TET (DNA hydroxymethylase), DNA methyltransferase, DNA demethylase, and DNA methylation (5mC) phenotype. Moreover, ELVs revert OAβ-triggered telomere length (TL) attrition as well as upregulation of telomerase reverse transcriptase (TERT) expression fostering dendrite protection and neuronal survival. Thus, ELVs modulate epigenomic resiliency by pleiotropic interrelated signaling.